United States· US:58468-0080_5c65708a-7f79-4d63-b4a9-b2b1a2d86bdd
Thymoglobulin
A medicinal product containing anti-thymocyte globulin (rabbit), registered in United States by Genzyme Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Anti-thymocyte Globulin (Rabbit)
- Manufacturer
- Genzyme Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1158468008011 VIAL, GLASS in 1 CARTON (58468-0080-1) / 5 mL in 1 VIAL, GLASS
Regulatory notes
Same medicine, other countries
Anti-thymocyte globulin (rabbit) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandGrafalon
- CzechiaGRAFALONNeovii Biotech GmbH, Gräfelfing
- United KingdomGrafalon 100mg/5ml concentrate for solution for infusion vialsImported (Germany)
- SpainGRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONNeovii Biotech Gmbh
- IrelandThymoglobuline 25 mg powder for solution for infusionSanofi B.V.
- NetherlandsGrafalon 20 mg/ml concentraat voor oplossing voor infusieNeovii Biotech GmbH
- CanadaTHYMOGLOBULINSANOFI-AVENTIS CANADA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/110a31d9-4399-432b-b769-e33c6628ac05 GET /v1/drugs/110a31d9-4399-432b-b769-e33c6628ac05?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "D7RD81HE4W",
"rxcui": null,
"inchikey": null,
"display_name": "LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN",
"substance_type": "structurallyDiverse",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"bbd8ab99-552e-4b81-aca4-6b0c7af8b9ae": {
"match": "brand_token",
"title": "THYMOGLOBULIN (ANTI-THYMOCYTE GLOBULIN (RABBIT)) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENZYME CORPORATION]",
"spl_version": "21",
"published_date": "2026-02-13"
}
},
"productid": "58468-0080_5c65708a-7f79-4d63-b4a9-b2b1a2d86bdd",
"productndc": "58468-0080",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN",
"proprietary_name": "Thymoglobulin",
"active_ingred_unit": "mg/mL",
"application_number": "BLA103869",
"marketing_category": "BLA",
"nonproprietary_name": "Anti-thymocyte Globulin (Rabbit)",
"start_marketing_date": "19981230",
"active_numerator_strength": "5"
}See everything about anti-thymocyte globulin (rabbit).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.